These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25190097)

  • 1. Molecular pathophysiology of metabolic effects of antipsychotic medications.
    Ballon JS; Pajvani U; Freyberg Z; Leibel RL; Lieberman JA
    Trends Endocrinol Metab; 2014 Nov; 25(11):593-600. PubMed ID: 25190097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypical antipsychotic induced weight gain and metabolic disorders].
    Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
    Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.
    Reynolds GP; Kirk SL
    Pharmacol Ther; 2010 Jan; 125(1):169-79. PubMed ID: 19931306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of antipsychotic-induced weight gain.
    McIntyre RS; Mancini DA; Basile VS
    J Clin Psychiatry; 2001; 62 Suppl 23():23-9. PubMed ID: 11603882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicians' recognition of the metabolic adverse effects of antipsychotic medications.
    Buckley PF; Miller DD; Singer B; Arena J; Stirewalt EM
    Schizophr Res; 2005 Nov; 79(2-3):281-8. PubMed ID: 15964743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic risk during antipsychotic treatment.
    Newcomer JW
    Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms.
    Gonçalves P; Araújo JR; Martel F
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):1-16. PubMed ID: 25523882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances.
    Kao AC; Rojnic Kuzman M; Tiwari AK; Zivkovic MV; Chowdhury NI; Medved V; Kekin I; Zai CC; Lieberman JA; Meltzer HY; Bozina T; Bozina N; Kennedy JL; Sertic J; Müller DJ
    J Psychiatr Res; 2014 Jul; 54():36-42. PubMed ID: 24725652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.
    Meltzer HY
    J Clin Psychiatry; 2001; 62 Suppl 27():35-9; discussion 40-1. PubMed ID: 11806488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic-induced weight gain: can the energy balance gene variants help us tip the scales?
    McCracken JT
    Pharmacogenomics; 2014 Mar; 15(4):403-6. PubMed ID: 24624905
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.
    Mizuno Y; Suzuki T; Nakagawa A; Yoshida K; Mimura M; Fleischhacker WW; Uchida H
    Schizophr Bull; 2014 Nov; 40(6):1385-403. PubMed ID: 24636967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design.
    Coccurello R; Moles A
    Pharmacol Ther; 2010 Sep; 127(3):210-51. PubMed ID: 20493213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antipsychotic medications on appetite, weight, and insulin resistance.
    Deng C
    Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.